Oregon

Florida woman with metastatic pancreatic cancer participates in groundbreaking clinical trial of adoptive cellular therapy only available at Providence Cancer Institute.

Two new clinical trials available at Providence will evaluate whether a combination of medications are effective and safe therapies for people with metastatic melanoma and metastatic uveal melanoma.

Researchers of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, will present their latest cancer immunotherapy data at Immunology2022 in May.

Providence Chief Executive of Behavior Health Robin Henderson shares how to protect your mental health in the face of global problems.

Investigator-initiated clinical trial at Providence Cancer Institute to evaluate the safety and efficacy of using a combination of immunotherapy and radiation therapy on tumors.

You can donate a bike to any one of 23 locations throughout the Portland Metro area, including 11 Providence locations, from 9 a.m. to 1 p.m. on April 30.

Register for a free virtual education event on April 19 for Mantle Cell Lymphoma patients, presented by the Leukemia & Lymphoma Society (LLS) and Providence Cancer Institute of Oregon.

A new phase I clinical trial available at Providence Cancer Institute of Oregon will evaluate the efficacy of new immunotherapy designed to modulate the immune system in blood cancer patients.

Providence Cancer Institute of Oregon and Pancreatic Cancer Action Network are partnering to promote awareness and research for pancreatic cancer through two community events this April.

Clinical studies focus on finding new ways to treat colorectal cancer, prevent recurrence and improve survival outcomes.

Local partner Health Share of Oregon is using a St. Joseph Community Partnership Fund grant to create stable housing opportunities for those at risk of homelessness.

Providence medical oncologist and medical director of gastrointestinal oncology talks about his career in oncology and his passion for cancer research.

Gerry Frank, whose special concern for children launched the The Gerry Frank Center for Children at Providence St. Vincent Medical Center, passed away on Sunday, March 13.

Providence medical oncologist Dr. Janet Ruzich accepts LLS Man & Woman of the Year nomination and joins philanthropic campaign to raise funds for local blood cancer research.

People with gallbladder cancer, bile duct cancer or pancreatic cancer may be eligible to participate in new clinical trials available at Providence Cancer Institute of Oregon.

Gynecologic cancer patients and their caregivers are invited to attend a free, virtual education event on March 9.

The Better Outcomes thru Bridges (BOB) Programs focus on serving some of our community’s most vulnerable and underserved people.

Providence initiatives in genomic medicine, immunotherapy research and cancer screening support Cancer Moonshot's goal to decrease the death rate from cancer by 50 percent in 25 years.

Researchers at Providence Cancer Institute are studying how well two surgical procedures work in reducing the risk of ovarian cancer for women with BRCA1 mutations.